Drug intelligence / Profile preview

MK-4232

Development stage
Unknown
Lead developer
Merck
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

MK-4232 is a highly potent, central nervous system (CNS)-penetrant antagonist of the calcitonin gene-related peptide (CGRP) receptor. It was developed as a radiolabeled positron emission tomography (PET) tracer to visualize and quantify CGRP receptor distribution in the brain. The compound was derived from modifications of the CGRP receptor antagonist MK-3207 to enhance CNS penetrance and allow for radiolabeling with carbon-11. [(11)C]MK-4232 has been used in preclinical and clinical imaging studies to map CGRP receptors, which are implicated in migraine pathophysiology. The highest concentrations of binding were observed in the cerebellum and brainstem regions of both rhesus monkeys and humans[1][2][3][4][6].

Other names
[(11)C]MK-4232[11C]MK-42328Compound 8Compound8Compound-8
02

Targets

Calcitonin gene-related peptide type 1 receptor

Beyond the preview

Go deeper on MK-4232.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MK-4232.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call